Micronucleus induction in somatic cells of mice as evaluated after 1,3- butadiene inhalation

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 397, Issue 1, 1998, Pages 11-20

  Stephanou, G ^a   Russo, A ^b   Vlastos, D ^a   Andrianopoulos, C ^a   Demopoulos, N A ^a  

^a UNIVERSITY OF PATRAS   (Greece)

^b UNIVERSITY OF PADOVA   (Italy)

Author keywords

1,3 Butadiene; Micronucleus; Peripheral blood reticulocyte; Splenocyte

Indexed keywords

1,3 BUTADIENE;

ANIMAL CELL; ARTICLE; CHROMOSOME BREAKAGE; CYTOPATHOGENIC EFFECT; DRUG EFFECT; GENE FREQUENCY; GENE INDUCTION; MALE; MICRONUCLEUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; RETICULOCYTE; SPLEEN CELL; TOXICITY TESTING;

ANIMALS; BUTADIENES; DNA DAMAGE; ENVIRONMENTAL POLLUTION; IMMUNOHISTOCHEMISTRY; KINETOCHORES; MALE; MICE; MICE, INBRED STRAINS; MICRONUCLEI, CHROMOSOME-DEFECTIVE; MICRONUCLEUS TESTS; MUTAGENS; RETICULOCYTES; SPLEEN; TIME FACTORS;

ANIMALIA;

EID: 0032536173     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0027-5107(97)00191-7     Document Type: Article

References (40)

1. U.S. Environmental Protection Agency Preliminary draft list of categories and subcategories under section 112 of the Clean Air. Act. Fed. Reg. 56:1991;28548-28557.
2. IARC, Monographs on the evaluation of the carcinogenic Risk of Chemicals to Humans, Vol. 54, International Agency for Research on Cancer, Lyon, 1992, pp. 237-285.
3. P.J. Landrigan, Critical assessment of epidemiological studies on the carcinogenicity of 1,3-butadiene and styrene, in: M. Sorsa, K. Peltonen, H. Vainio, K. Hemminki (Eds.), Butadiene and Styrene: Assessment of Health Hazards, Vol. 127, IARC Scientific Publications, Lyon, 1993, pp. 375-388.
4. B.J. Divine, J.K. Wendt, C.M. Hartman, Cancer mortality among workers at a butadiene production facility, in: M. Sorsa, K. Peltonen, H. Vainio, K. Hemminki (Eds.), Butadiene and Styrene: Assessment of Health Hazards, Vol. 127, IARC Scientific Publications, Lyon, 1993, pp. 345-362.
5. Arce G.T., Vincent D.R., Cunningham M.J., Choy W.N., Sarrif A.M. In vitro and in vivo genotoxicity of 1,3-butadiene and metabolites. Environ. Health Perspect. 86:1990;75-78.
6. Cunningham M.J., Choy W.N., Theall Arce G., Rickard L.B., Vlachos D.A., Kinney L.A., Sarrif A.M. In vivo sister chromatid exchange and micronucleous induction studies with 1,3-butadiene in B6C3F1 mice and Sprague-Dawley rats. Mutagenesis. 1:1986;449-452.
7. Autio K., Renzi L., Catalan J., Albrecht O.E., Sorsa M. Induction of micronuclei in peripheral blood and bone marrow erythrocytes of rats and mice exposed to 1,3- butadiene inhalation. Mutation Res. 309:1994;315-320.
8. Xiao Y., Tates A.D. Clastogenic effects of 1,3-butadiene and its metabolites, 1,2-epoxybutene and 1,2,3,4-diepoxybutane in splenocytes and germ cells of rats and mice in vivo. Environ. Mol. Mutagen. 26:1995;97-108.
9. Adler I.-D., Filser J.G., Gassner P., Kessler W., Schoneich J., Schriever-Schwemmer G. Heritable translocations induced by inhalation exposure of male mice to 1,3-butadiene. Mutation Res. 347:1995;121-127.
10. Adler I.-D., Anderson D. Dominant lethal effects after inhalation exposure to 1,3-butadiene. Mutation Res. 309:1994;295-297.
11. Recio L., Meyer K.G. Increased frequency of mutations at A:T base pairs in the bone marrow of B6C3F1 lacl transgenic mice exposed to 1,3-butadiene. Environ. Mol. Mutagen. 26:1995;1-8.
12. Xiao Y., de Stoppelaar J.M., Hoebee B., Schriever-Schwemmer G., Adler I.-D., Tates A.D. Analysis of micronuclei induced by 1,3-butadiene and its metabolites using fluorescence in situ hybridization. Mutation Res. 354:1996;49-57.
13. Sorsa M., Autio K., Demopoulos N.A., Jarventaus J., Rossner P., Sram R.J., Stephanou G., Vlachodimitropoulos D. Human cytogenetic biomonitoring of occupational exposure to 1,3-butadiene. Mutation Res. 309:1994;321-326.
14. Tates A.D., van Dam F.J., de Zwart F.A., Darroudi F., Natarajan A.T., Rossner P., Peterkova K., Peltonen K., Demopoulos N.A., Stephanou G., Vlachodimitropoulos D., Sram R.J. Biological effect monitoring in industrial workers from the Czech Republic exposed to low levels of butadiene. Toxicology. 113:1996;91-99.
15. Owen P.E., Glaister J.R., Gaunt I.F., Pullinger D.H. Inhalation toxicity studies with 1,3-butadiene. 3. Two year toxicity/carcinogenicity studies in rats Am. Ind. Hyg. Assoc. J. 48:1987;407-413.
16. 1 mice at low exposure concentrations. Cancer Res. 50:1990;6592-6599.
17. Malvoisin E., Roberfroid M. Hepatic microsomal metabolism of 1,3-butadiene. Xenobiotica. 12:1982;137-144.
18. Russo A., Nogara C., Renzi L., Tommasi A.M. Micronucleous induction in germ and somatic cells of the mouse after exposure to the butadiene metabolites diepoxybutane and epoxybutene. Mutation Res. 390:1997;129-139.
19. Bond J.A., Dahl A.R., Henderson R.F., Birnbaum L.S. Species differences in the distribution of inhaled butadiene in tissues. Am. Ind. Hyg. Assoc. J. 48:1987;867-872.
20. Dahl A.R., Bechtold E.W., Bond J.A., Henderson R.F., Mauderly J.L., Muggenburg B.A., Sun J.D., Birnbaum L.S. Species differences in the metabolism and disposition of inhaled 1,3-butadiene and isoprene. Environ. Health Perspect. 86:1990;65-69.
21. Csanady G.A., Guengerich F.P., Bond J.A. Comparison of the biotransformation of 1,3-butadiene and its metabolite, butadiene monoepoxide, by hepatic and pulmonary tissues from humans, rats and mice. Carcinogenesis. 13(7):1992;1143-1153.
22. Sobels F.H. Models and assumptions underlying genetic risk assessment. Mutation Res. 114:1989;93-105.
23. F. Pacchierotti, I.-D. Adler, D. Anderson, M. Brinkworth, N.A. Demopoulos, J. Lahdetie, S. Osterman-Golkar, K. Peltonen, A. Russo, A.D. Tates, R. Waters, Genetic effects of 1,3-butadiene and associated risk for heritable damage, Mutation Res. 381 (1997) this issue.
24. A.M. Tommasi, S. de Conti, M. Dobrynska, A. Russo, Evaluation and characterization of micronuclei in early spermatids of mice exposed to butadiene, Mutation Res. 381 (1997) this issue.
25. O.E. Albrecht, J.G. Filser, H.G. Neumann, Biological monitoring of 1,3-butadiene: species differences in haemoglobin binding in rat and mouse, in: M. Sorsa, K. Peltonen H. Vainio, K. Hemminki (Eds.), Butadiene and Styrene: Assessment of Health Hazards, Vol. 127, IARC Scientific Publications, Lyon, 1993, pp. 135-142.
26. Fenech M. The cytokinesis-block micronucleus technique: a detailed description of the method and its application to genotoxicity studies in human populations. Mutation Res. 285:1993;35-44.
27. R.R. Sokal, F.J. Rohlf, Biometry, W.H. Freeman and Co., 1981, New York.
28. CSGMT, The Collaborative Study Group for the Micronucleus Test Micronucleus test with mouse peripheral blood erythrocytes by acridine orange supravital staining: the summary report of the 5th collaborative study by CSGMT/JEMS MMM. Mutation Res. 278:1992;83-98.
29. Russo A., Dorigo E., Renzi L. The micronucleus assay in mouse peripheral blood reticulocytes demonstrates the transmission of chromosomal instability induced by mitomycin C and benzo(a)pyrene. Mutagenesis. 8:1993;407-410.
30. Degrassi F., Tanzarella C. Immunofluorescent staininig of kinetochores in micronuclei: a new assay for the detection of aneuploidy. Mutation Res. 203:1988;339-345.
31. Eastmond D.A., Tucker J.D. Identification of aneuploidy-inducing agents using cytokinesis-blocked human lymphocytes and an antikinetochore antibody. Environ. Mol. Mutagen. 13:1989;34-44.
32. Renzi L., Pacchierotti F., Russo A. The centromere as a target for the induction of chromosome damage in resting and proliferating mammalian cells: assessment of mitomycin C-induced genetic damage at kinetochores and centromeres by a micronucleous test in mouse splenocytes. Mutagenesis. 11(2):1996;133-138.
33. Russo A., Tommasi A.M., Renzi L. Detection of minor and major satellite DNA in cytokinesis-blocked mouse splenocytes by a PRINS tandem labelling approach. Mutagenesis. 11(6):1996;547-552.
34. Stephanou G., Andrianopoulos C., Vlastos D., Demopoulos N.A., Rousso A. Induction of micronuclei and sister chromatid exchanges in mouse splenocytes after exposure to the butadiene metabolite 3,4-epoxy-butene. Mutagenesis. 12(6):1997;. in press.
35. Darroudi F., Farooqi Z., Benova D., Natarajan A.T. The mouse splenocyte assay, in vivo/in vitro system for biological monitoring: studies with X-rays, fission neutrons and bleomycin. Mutation Res. 272:1992;237-248.
36. Jauhar P.P., Henika P.R., MacGregor J.T., Wehr C.M., Shelby M.D., Murphy S.A., Margolin B.H. 1,3-butadiene: induction of micronucleated erythrocytes in the peripheral blood of B6C3F1 mice exposed by inhalation for 13 weeks. Mutation Res. 209:1988;171-176.
37. Irons R.D., Oshimura M., Barrett J.C. Chromosome aberrations in mouse bone marrow cells following in vivo exposure to 1,3-butadiene. Carcinogenesis. 8(11):1987;1711-1714.
38. Irons R.D., S Stillman W., Shah R.S., Morris M.S., Higuchi M. Phenotypic characterization of 1,3-butadiene-induced thymic lymphoma in male B6C3F1 mice. Toxicologist. 6:1986;21.
39. Adler I.-D., Cao J.G., Filser P., Gassner P., Kaessler W., Kliesch U., Neuhauser -Klaus A., Nusse M. Mutagenicity of 1,3-butadiene inhalation in somatic and germinal cells of mice. Mutation Res. 309:1994;307-314.
40. Vlachodimitropoulos D., Norppa H., Autio K., Catalan J., Hirvonen A., Tasa G., Uuskula M., Demopoulos N.A., Sorsa M. GSTT1-dependent induction of centromere-negative and -positive micronuclei by 1,2:3,4-diepoxybutane in cultured human lymphocytes. Mutagenesis. 12(5):1997;397-403.